{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:23:55Z","timestamp":1762507435038},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,28]],"date-time":"2018-05-28T00:00:00Z","timestamp":1527465600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"the GE Healthcare Korea"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Osteoporosis and Sarcopenia"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.afos.2018.05.003","type":"journal-article","created":{"date-parts":[[2018,6,11]],"date-time":"2018-06-11T21:12:17Z","timestamp":1528751537000},"page":"73-76","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinical significance of trabecular bone score for prediction of pathologic fracture risk in patients with multiple myeloma"],"prefix":"10.1016","volume":"4","author":[{"given":"Eun Mi","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bukyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.afos.2018.05.003_bib1","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJMra1011442","article-title":"Multiple myeloma","volume":"364","author":"Palumbo","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.afos.2018.05.003_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.afos.2018.05.003_bib3","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1359\/JBMR.041131","article-title":"Fracture risk with multiple myeloma: a population-based study","volume":"20","author":"Melton","year":"2005","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.afos.2018.05.003_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1756-9966-27-11","article-title":"Effect of pathologic fractures on survival in multiple myeloma patients: a case control study","volume":"27","author":"Sonmez","year":"2008","journal-title":"J\u00a0Exp Clin Canc Res"},{"key":"10.1016\/j.afos.2018.05.003_bib5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/bjh.14815","article-title":"Increased fracture risk in plasma cell dyscrasias is associated with poorer overall survival","volume":"179","author":"McIlroy","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.afos.2018.05.003_bib6","first-page":"567","article-title":"Sequential analysis of biochemical markers of bone resorption and bone densitometry in multiple myeloma","volume":"89","author":"Abildgaard","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.afos.2018.05.003_bib7","first-page":"1244","article-title":"Diagnostic challenges in osteoporosis. Indications for bone densitometry and establishing secondary causes","volume":"47","author":"Karsh","year":"2001","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.afos.2018.05.003_bib8","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0002-9343(92)90190-M","article-title":"Bone densitometry in patients with multiple myeloma","volume":"93","author":"Mariette","year":"1992","journal-title":"Am J Med"},{"key":"10.1016\/j.afos.2018.05.003_bib9","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/1097-0142(19951101)76:9<1559::AID-CNCR2820760910>3.0.CO;2-R","article-title":"Evolution of bone densitometry in patients with myeloma treated with conventional or intensive therapy","volume":"76","author":"Mariette","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.afos.2018.05.003_bib10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3348\/jksr.2013.68.1.63","article-title":"Analysis of bone mineral density in multiple myeloma: a comparison of bone mineral density with plain radiography, magnetic resonance imaging, and clinical staging","volume":"68","author":"Kim","year":"2013","journal-title":"J\u00a0Kor Soc Radiol"},{"key":"10.1016\/j.afos.2018.05.003_bib11","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1600-0609.1996.tb01395.x","article-title":"Assessment of bone involvement in patients with multiple myeloma using bone densitometry","volume":"57","author":"Abildgaard","year":"1996","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.afos.2018.05.003_bib12","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/hon.2303","article-title":"Bone mineral density utilization in patients with newly diagnosed multiple myeloma","volume":"35","author":"Muchtar","year":"2017","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.afos.2018.05.003_bib13","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1002\/jbmr.2443","article-title":"Association of QCT bone mineral density and bone structure with vertebral fractures in patients with multiple myeloma","volume":"30","author":"Borggrefe","year":"2015","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.afos.2018.05.003_bib14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1749-6632.2009.05348.x","article-title":"Biomechanical computed tomography-noninvasive bone strength analysis using clinical computed tomography scans","volume":"1192","author":"Keaveny","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.afos.2018.05.003_bib15","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1359\/jbmr.070728","article-title":"Structural determinants of vertebral fracture risk","volume":"22","author":"Melton","year":"2007","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.afos.2018.05.003_bib16","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1148\/radiol.11101746","article-title":"Multiple myeloma: microstructural analysis of lumbar trabecular bones in patients without visible bone lesions\u2013preliminary results","volume":"260","author":"Takasu","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.afos.2018.05.003_bib17","doi-asserted-by":"crossref","first-page":"990","DOI":"10.4158\/EP151019.RA","article-title":"Beyond DXA: advances in clinical applications of new bone imaging technology","volume":"22","author":"Pawlowska","year":"2016","journal-title":"Endocr Pract"},{"key":"10.1016\/j.afos.2018.05.003_bib18","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s11914-017-0410-z","article-title":"The trabecular bone score (TBS) complements DXA and the FRAX as a fracture risk assessment tool in routine clinical practice","volume":"15","author":"Hans","year":"2017","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.afos.2018.05.003_bib19","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.bone.2015.05.016","article-title":"Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice","volume":"78","author":"Harvey","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.afos.2018.05.003_bib20","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1590\/0004-2730000003456","article-title":"Trabecular bone score: perspectives of an imaging technology coming of age","volume":"58","author":"Silva","year":"2014","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.1016\/j.afos.2018.05.003_bib21","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.bone.2008.01.027","article-title":"The pathogenesis of the bone disease of multiple myeloma","volume":"42","author":"Edwards","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.afos.2018.05.003_bib22","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1634\/theoncologist.2008-0087","article-title":"Bone-resorbing cells in multiple myeloma: osteoclasts, myeloma cell polykaryons, or both?","volume":"14","author":"Silvestris","year":"2009","journal-title":"Oncol"},{"key":"10.1016\/j.afos.2018.05.003_bib23","first-page":"76","article-title":"Multiple myeloma and bone disease: pathogenesis and current therapeutic approaches","volume":"14","author":"Papadopoulou","year":"2010","journal-title":"Hippokratia"},{"key":"10.1016\/j.afos.2018.05.003_bib24","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/978-1-4614-6176-0_9","article-title":"Targeted therapy of multiple myeloma","volume":"779","author":"Dolloff","year":"2013","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.afos.2018.05.003_bib25","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1056\/NEJMoa053583","article-title":"Thalidomide and hematopoietic-cell transplantation for multiple myeloma","volume":"354","author":"Barlogie","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.afos.2018.05.003_bib26","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1081\/CNV-120030218","article-title":"Development of the proteasome inhibitor Velcade (Bortezomib)","volume":"22","author":"Adams","year":"2004","journal-title":"Canc Invest"},{"key":"10.1016\/j.afos.2018.05.003_bib27","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ejrad.2009.02.005","article-title":"Imaging in multiple myeloma","volume":"70","author":"Delorme","year":"2009","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.afos.2018.05.003_bib28","first-page":"874","article-title":"Staging of multiple myeloma with MRI: comparison to MSCT and conventional radiography","volume":"44","author":"Baur-Melnyk","year":"2004","journal-title":"Radiologe"}],"container-title":["Osteoporosis and Sarcopenia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405525518300104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405525518300104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T10:17:29Z","timestamp":1604398649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405525518300104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S2405525518300104"],"URL":"https:\/\/doi.org\/10.1016\/j.afos.2018.05.003","relation":{},"ISSN":["2405-5255"],"issn-type":[{"value":"2405-5255","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical significance of trabecular bone score for prediction of pathologic fracture risk in patients with multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Osteoporosis and Sarcopenia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.afos.2018.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Korean Society of Osteoporosis. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}